Evidence map›Paper›PMID 33691586›Full record

ArticleAutophagy2021

Coxsackievirus B3 targets TFEB to disrupt lysosomal function.

Yasir Mohamud, Hui Tang, Yuan Chao Xue, Huitao Liu, Chen Seng Ng, Amirhossein Bahreyni, Honglin Luo

Open access · hybridAbstract read
In one paragraph

Article in Autophagy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tacrolimus inhibits CVB3-targeted regulation of TFEB by PPP3/calcineurin.Frontiers in cellular and infection microbiology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. The role of autophagy in viral infections.Journal of biomedical science · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yasir MohamudCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Hui TangCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Yuan Chao XueCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Huitao LiuCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Chen Seng NgCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Amirhossein BahreyniCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Honglin LuoCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
University of British Columbia · CASt. Paul's Hospital · CA

Funding

CIHR PJT 159546CIHR PJT-173318
6 · The paper itself

Abstract

Coxsackievirus B3 (CVB3) is a prevalent etiological agent for viral myocarditis and neurological disorders, particularly in infants and young children. Virus-encoded proteinases have emerged as cytopathic factors that contribute to disease pathogenesis in part through targeting the cellular recycling machinery of autophagy. Although it is appreciated that CVB3 can usurp cellular macroautophagy/autophagy for pro-viral functions, the precise mechanisms by which viral proteinases disrupt autophagy remain incompletely understood. Here we identified TFEB (transcription factor EB), a master regulator of autophagy and lysosome biogenesis, as a novel target of CVB3 proteinase 3 C. Time-course infections uncovered a significant loss of full-length TFEB and the emergence of a lower-molecular mass (~63 kDa) fragment. Cellular and

Indexed as

AutophagyEnterovirus B, HumanBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell NucleusHumansLysosomesProtein TransportBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTFEB protein, human3C proteinaseautophagyCoxsackievirus B3enteroviruslysosomeTFEB

Identifiers

PMID33691586
PMCPMC8726691
OpenAlexW3135399731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.